Advertisement

Fertilité et cancer du testicule

  • É. Huyghe
  • P.-F. Thonneau
Chapter
  • 194 Downloads
Part of the Monographies en urologie book series (MONOGRAPHIES)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Huyghe E, Matsuda T, Thonneau P (2003) Increasing incidence of testicular cancer worldwide: a review. J Urol 170: 5–11PubMedCrossRefGoogle Scholar
  2. 2.
    Aareleid T Sant, M, Hedelin G (1998) Improved survival for patients with testicular cancer in Europe since 1978. Eur J Cancer 34: 2236–40CrossRefGoogle Scholar
  3. 3.
    Bosl GJ, Motzer RJ (1997) Testicular germ-cell cancer. N Engl J Med 337: 242–53PubMedCrossRefGoogle Scholar
  4. 4.
    Francis R, Bower M, Brunstrom G et al. (2000) Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options. Eur J Cancer 36: 1925–32PubMedCrossRefGoogle Scholar
  5. 5.
    Botchan A, Hauser R, Yogev L et al. (1997) Testicular cancer and spermatogenesis. Hum Reprod 12: 755–8PubMedCrossRefGoogle Scholar
  6. 6.
    Gandini L, Lombardo F, Salacone P et al. (2003) Testicular cancer and Hodgkin’s disease: evaluation of semen quality. Hum Reprod 18: 796–801PubMedCrossRefGoogle Scholar
  7. 7.
    Padron OF, Sharma RK, Thomas AJ, Jr. et al. (1997) Effects of cancer on spermatozoa quality after cryopreservation: a 12-year experience. Fertil Steril 67: 326–31PubMedGoogle Scholar
  8. 8.
    Swerdlow AJ, Huttly SR, Smith PG (1989) Testis cancer: post-natal hormonal factors, sexual behaviour and fertility. Int J Cancer 43: 549–53PubMedGoogle Scholar
  9. 9.
    United Kingdom Testicular Cancer Study Group (1994) Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise. BMJ 308: 1393–9Google Scholar
  10. 10.
    Moller H, Skakkebaek NE (1999) Risk of testicular cancer in subfertile men: case-control study. Bmj 318: 559–62PubMedGoogle Scholar
  11. 11.
    Fossa SD, Kravdal O (2000) Fertility in Norwegian testicular cancer patients. Br J Cancer 82: 737–41PubMedGoogle Scholar
  12. 12.
    Jacobsen R, Bostofte E, Engholm G et al. (2000) Fertility and offspring sex ratio of men who develop testicular cancer: a record linkage study. Hum Reprod 15: 1958–61PubMedGoogle Scholar
  13. 13.
    Spermon JR, Kiemeney LA, Meuleman EJ et al. (2003) Fertility in men with testicular germ cell tumors. Fertil Steril 79Suppl 3: 1543–9PubMedGoogle Scholar
  14. 14.
    Huyghe E, Matsuda T, Daudin M et al. (2004) Fertility after testicular cancer treatments: results of a large multicenter study. Cancer 100(4): 732–7PubMedCrossRefGoogle Scholar
  15. 15.
    Benson RC, Jr., Beard CM, Kelalis PP et al. (1991) Malignant potential of the cryptorchid testis. Mayo Clin Proc 66: 372–8PubMedGoogle Scholar
  16. 16.
    Moller H, Prener A, Skakkebaek NE (1996) Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: case-control studies in Denmark. Cancer Causes Control 7: 264–74PubMedGoogle Scholar
  17. 17.
    Chilvers C, Dudley NE, Gough MH et al. (1986) Undescended testis: the effect of treatment on subsequent risk of subfertility and malignancy. J Pediatr Surg 21: 691–6PubMedGoogle Scholar
  18. 18.
    Abratt RP, Reddi VB, Sarembock LA (1992) Testicular cancer and cryptorchidism. Br J Urol 70: 656–9PubMedGoogle Scholar
  19. 19.
    Strader CH, Weiss NS, Daling JR et al. (1988) Cryptorchism, orchiopexy, and the risk of testicular cancer. Am J Epidemiol 127: 1013–8PubMedGoogle Scholar
  20. 20.
    Palmer JM (1991) The undescended testicle. Endocrinol Metab Clin North Am 20: 231–40PubMedGoogle Scholar
  21. 21.
    Lee PA, Coughlin MT (2001) Fertility after bilateral cryptorchidism. Evaluation by paternity, hormone, and semen data. Horm Res 55: 28–32PubMedCrossRefGoogle Scholar
  22. 22.
    Berthelsen JG, Skakkebaek NE (1983) Gonadal function in men with testis cancer. Fertil Steril 39: 68–75PubMedGoogle Scholar
  23. 23.
    Rajpert-De Meyts E, Jorgensen N, Brondum-Nielsen K et al. (1998) Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. Apmis 106: 198–204; discussion 204-6PubMedGoogle Scholar
  24. 24.
    Skakkebaek NE, Rajpert-De Meyts E, Main KM (2001) Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 16: 972–8PubMedGoogle Scholar
  25. 25.
    Skakkebaek NE, Holm M, Hoei-Hansen C et al. (2003) Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: evidence from 20 adult patients with signs of maldevelopment of the testis. Apmis 111: 1–9; discussion 9–11PubMedCrossRefGoogle Scholar
  26. 26.
    Carroll PR, WF Whitmore Jr., Herr HW et al. (1987) Endocrine and exocrine profiles of men with testicular tumors before orchiectomy. J Urol 137: 420–3PubMedGoogle Scholar
  27. 27.
    Hansen PV, Trykker H, Andersen J et al. (1989) Germ cell function and hormonal status in patients with testicular cancer. Cancer 64: 956–61PubMedGoogle Scholar
  28. 28.
    Nakazumi H, Sasano H, Maehara I et al. (1996) Estrogen metabolism and impaired spermatogenesis in germ cell tumors of the testis. J Clin Endocrinol Metab 81: 1289–95PubMedCrossRefGoogle Scholar
  29. 29.
    Kuczyk M, Machtens S, Bokemeyer C et al. (2000) Sexual function and fertility after treatment of testicular cancer. Curr Opin Urol 10: 473–7PubMedCrossRefGoogle Scholar
  30. 30.
    Lehmann D, Muller H (1987) Analysis of the autoimmune response in an ‘in situ’ carcinoma of the testis. Int J Androl 10: 163–8PubMedGoogle Scholar
  31. 31.
    Guazzieri S, Lembo A, Ferro G et al. (1985) Sperm antibodies and infertility in patients with testicular cancer. Urology 26: 139–42PubMedCrossRefGoogle Scholar
  32. 32.
    Foster RS, Rubin LR, McNulty A et al. (1991) Detection of antisperm-antibodies in patients with primary testicular cancer. Int J Androl 14: 179–85PubMedGoogle Scholar
  33. 33.
    Hobarth K, Klingler HC, Maier U et al. (1994) Incidence of antisperm antibodies in patients with carcinoma of the testis and in subfertile men with normogonadotropic oligoasthenoteratozoospermia. Urol Int 52: 162–5PubMedGoogle Scholar
  34. 34.
    Joly F, Heron JF, Kalusinski L et al. (2002) Quality of life in long-term survivors of testicular cancer: a population-based case-control study. J Clin Oncol 20: 73–80PubMedCrossRefGoogle Scholar
  35. 35.
    Gritz ER, Wellisch DK, Wang HJ et al. (1989) Long-term effects of testicular cancer on sexual functioning in married couples. Cancer 64: 1560–7PubMedGoogle Scholar
  36. 36.
    Douchez J, Droz JP, Desclaux B et al. (1993) Quality of life in long-term survivors of nonseminomatous germ cell testicular tumors. J Urol 149: 498–501PubMedGoogle Scholar
  37. 37.
    Schover LR, Rybicki LA, Martin BA et al. (1999) Having children after cancer. A pilot survey of survivors’ attitudes and experiences. Cancer 86: 697–709PubMedCrossRefGoogle Scholar
  38. 38.
    Herr HW, Bar-Chama N, O’sullivan M et al. (1998) Paternity in men with stage I testis tumors on surveillance. J Clin Oncol 16: 733–4PubMedGoogle Scholar
  39. 39.
    Arai Y, Kawakita M, Okada Y et al. (1997) Sexuality and fertility in long-term survivors of testicular cancer. J Clin Oncol 15: 1444–8PubMedGoogle Scholar
  40. 40.
    Hansen SW, Berthelsen JG, von der Maase H (1990) Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance. J Clin Oncol 8: 1695–8PubMedGoogle Scholar
  41. 41.
    Hartmann JT, Albrecht C, Schmoll HJ et al. (1999) Long-term effects on sexual function and fertility after treatment of testicular cancer. Br J Cancer 80: 801–7PubMedCrossRefGoogle Scholar
  42. 42.
    Bohlen D, Burkhard FC, Mills R et al. (2001) Fertility and sexual function following orchiectomy and 2 cycles of chemotherapy for stage I high risk nonseminomatous germ cell cancer. J Urol 165: 441–4PubMedGoogle Scholar
  43. 43.
    Rowley MJ, Leach DR, Warner GA et al. (1974) Effect of graded doses of ionizing radiation on the human testis. Radiat Res 59: 665–78PubMedGoogle Scholar
  44. 44.
    Shalet SM (2004) Spermatogenesis after cancer treatment; damage and recovery. in Parenthood after cancer: Today’s options and tomorrow’s hopes. HoustonGoogle Scholar
  45. 45.
    Bachaud JM Alzieu, C, Bujan L (1995) Effets de la radiothérapie sur la fonction testiculaire de l’adulte. Andrologie 5: 476–85CrossRefGoogle Scholar
  46. 46.
    Centola GM, Keller JW, Henzler M et al. (1994) Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J Androl 15: 608–13PubMedGoogle Scholar
  47. 47.
    Meistrich ML, van Beek ME (1990) Radiation sensitivity of the human testis. Advances Radiat Biol 14: 227–68Google Scholar
  48. 48.
    Hahn EW, Feingold SM, Nisce L (1976) Aspermia and recovery of spermatogenesis in cancer patients following incidental gonadal irradiation during treatment: a progress report. Radiology 119: 223–5PubMedGoogle Scholar
  49. 49.
    DeSantis M, Albrecht W, Holtl W et al. (1999) Impact of cytotoxic treatment on longterm fertility in patients with germ-cell cancer. Int J Cancer 83: 864–5PubMedCrossRefGoogle Scholar
  50. 50.
    Nijman JM, Schraffordt Koops H, Kremer J et al. (1987) Gonadal function after surgery and chemotherapy in men with stage II and III nonseminomatous testicular tumors. J Clin Oncol 5: 651–6PubMedGoogle Scholar
  51. 51.
    Johnson DH, Hainsworth JD, Linde RB et al. (1984) Testicular function following combination chemotherapy with cis-platin, vinblastine, and bleomycin. Med Pediatr Oncol 12: 233–8PubMedGoogle Scholar
  52. 52.
    Petersen PM, Hansen SW, Giwercman A et al. (1994) Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer. Ann Oncol 5: 355–8PubMedGoogle Scholar
  53. 53.
    Pont J, Albrecht W (1997) Fertility after chemotherapy for testicular germ cell cancer. Fertil Steril 68: 1–5PubMedCrossRefGoogle Scholar
  54. 54.
    Maines MD, Sluss PM, Iscan M (1990) Cis-Platinum-mediated decrease in serum testosterone is associated with depression of luteinizing hormone receptors and cytochrome P-450scc in rat testis. Endocrinology 126: 2398–406PubMedCrossRefGoogle Scholar
  55. 55.
    Pogach, LM, Y Lee, S Gould et al. (1989) Characterization of cis-platinum-induced Sertoli cell dysfunction in rodents. Toxicol Appl Pharmacol 98: 350–61PubMedCrossRefGoogle Scholar
  56. 56.
    Seaman F, Sawhney P, Giammona CJ et al. (2003) Cisplatin-induced pulse of germ cell apoptosis precedes long-term elevated apoptotic rates in C57/BL/6 mouse testis. Apoptosis 8: 101–8PubMedCrossRefGoogle Scholar
  57. 57.
    Boekelheide K (2004) Mechanisms of toxic damage to spermatogenesis. in Parenthood after Cancer: Today’s options and tomorrow’s hopes. MD Anderson cancer center, Houston, TexasGoogle Scholar
  58. 58.
    Ishikawa T, Kamidono S, Fujisawa M (2004) Fertility after high-dose chemotherapy for testicular cancer. Urology 63: 137–40PubMedCrossRefGoogle Scholar
  59. 59.
    Donohue JP, Thornhill JA, Foster RS et al. (1993) Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer. Review of the Indiana University experience 1965–1989. Br J Urol 71: 326–35PubMedGoogle Scholar
  60. 60.
    Jacobsen KD, Ous S, Waehre H et al. (1999) Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection. Br J Cancer 80: 249–55PubMedCrossRefGoogle Scholar
  61. 61.
    Lass A, Abusheikha N, Akagbosu F et al. (1999) Cancer patients should be offered semen cryopreservation. Bmj 318: 1556PubMedGoogle Scholar
  62. 62.
    Hallak J, Hendin BN, Thomas AJ Jr. et al. (1998) Investigation of fertilizing capacity of cryopreserved spermatozoa from patients with cancer. J Urol 159: 1217–20PubMedGoogle Scholar
  63. 63.
    Agarwal A, Tolentino MV Jr., Sidhu RS et al. (1995) Effect of cryopreservation on semen quality in patients with testicular cancer. Urology 46: 382–9PubMedCrossRefGoogle Scholar
  64. 64.
    Kelleher S, Wishart SM, Liu PY et al. (2001) Long-term outcomes of elective human sperm cryostorage. Hum Reprod 16: 2632–9PubMedCrossRefGoogle Scholar
  65. 65.
    Anger JT, Gilbert BR, Goldstein M (2003) Cryopreservation of sperm: indications, methods and results. J Urol 170: 1079–84PubMedGoogle Scholar
  66. 66.
    Tomlinson MJ, Pacey AA (2003) Practical aspects of sperm banking for cancer patients. Hum Fertil (Camb) 6: 100–5CrossRefGoogle Scholar
  67. 67.
    Sibert L, Rives N, Rey D et al. (1999) Semen cryopreservation after orchidectomy in men with testicular cancer. BJU Int 84: 1038–42PubMedCrossRefGoogle Scholar
  68. 68.
    Rosenlund B, Sjoblom P, Tornblom M et al. (1998) In-vitro fertilization and intracytoplasmic sperm injection in the treatment of infertility after testicular cancer. Hum Reprod 13: 414–8PubMedCrossRefGoogle Scholar
  69. 69.
    Fossa SD, Aass N, Molne K (1989) Is routine pre-treatment cryopreservation of semen worthwhile in the management of patients with testicular cancer? Br J Urol 64: 524–9PubMedGoogle Scholar
  70. 70.
    Ragni G, Somigliana E, Restelli L et al. (2003) Sperm banking and rate of assisted reproduction treatment: insights from a 15-year cryopreservation program for male cancer patients. Cancer 97: 1624–9PubMedCrossRefGoogle Scholar
  71. 71.
    Hallak J, Sharma RK, Thomas AJ Jr. et al. (1998) Why cancer patients request disposal of cryopreserved semen specimens posttherapy: a retrospective study. Fertil Steril 69: 889–93PubMedCrossRefGoogle Scholar
  72. 72.
    Ward JA, Robinson J, Furr BJ et al. (1990) Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist. Cancer Res 50: 568–74PubMedGoogle Scholar
  73. 73.
    Johnson DH, Linde R, Hainsworth JD et al. (1985) Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on posttherapy fertility in male patients with lymphoma: preliminary observations. Blood 65: 832–6PubMedGoogle Scholar
  74. 74.
    Heidenreich A, Weissbach L, Holtl W et al. (2001) Organ sparing surgery for malignant germ cell tumor of the testis. J Urol 166: 2161–5PubMedGoogle Scholar
  75. 75.
    Huyghe E, Soulie M, Escourrou G et al. (2005) Conservative management of small testicular tumors relative to carcinoma in situ prevalence. J Urol 173(3): 820–3PubMedCrossRefGoogle Scholar
  76. 76.
    Schlatt S (2004) Cryopreservation and transplantation of spermatogonia for preservation of male fertility. in Parenthood after Cancer: Today’s options and tomorrow’s hopesGoogle Scholar
  77. 77.
    Patrizio P, Honoramooz A, Dobrinski I (2004) Experience with xenografts and issues for safe usage in humans. in Parenthood after Cancer: Today’s options and tomorrow’s hopes. MD Anderson cancer center, Houston, TexasGoogle Scholar
  78. 78.
    Marchetti F, Bishop JB, Lowe X et al. (2001) Etoposide induces heritable chromosomal aberrations and aneuploidy during male meiosis in the mouse. Proc Natl Acad Sci USA 98: 3952–7PubMedCrossRefGoogle Scholar
  79. 79.
    Hooser SB, van Dijk-Knijnenburg WC, Waalkens-Berendsen ID et al. (2000) Cisplatin-DNA adduct formation in rat spermatozoa and its effect on fetal development. Cancer Lett 151: 71–80PubMedCrossRefGoogle Scholar
  80. 80.
    Babosa M, Baki M, Bodrogi I et al. (1994) A study of children, fathered by men treated for testicular cancer, conceived before, during, and after chemotherapy. Med Pediatr Oncol 22: 33–8PubMedGoogle Scholar
  81. 81.
    Senturia YD, Peckham CS, Peckham MJ (1985) Children fathered by men treated for testicular cancer. Lancet 2: 766–9PubMedGoogle Scholar
  82. 82.
    Hansen PV, Glavind K, Panduro J et al. (1991) Paternity in patients with testicular germ cell cancer: pretreatment and post-treatment findings. Eur J Cancer 27: 1385–9PubMedGoogle Scholar
  83. 83.
    Auroux M (1995) Chimiothérapie anticancéreuse chez le mâle: risque pour la descendance. Andrologie 1995: 465–75Google Scholar
  84. 84.
    Meistrich ML (1993) Potential genetic risks of using semen collected during chemotherapy. Hum Reprod 8: 8–10PubMedGoogle Scholar
  85. 85.
    Fossa SD (2004) Parenthood in survivors after adulthood cancer and perinatal health in their offspring. in Parenthood after Cancer: Today’s options and tomorrow’s hopes. MD Anderson cancer center, Houston, TexasGoogle Scholar
  86. 86.
    Martin RH, Hildebrand K, Yamamoto J et al. (1986) An increased frequency of human sperm chromosomal abnormalities after radiotherapy. Mutat Res 174: 219–25PubMedCrossRefGoogle Scholar
  87. 87.
    Stahl O, Eberhard J, Jepson K et al. (2004) The impact of testicular carcinoma and its treatment on sperm DNA integrity. Cancer 100: 1137–44PubMedGoogle Scholar
  88. 88.
    Martin RH, Ernst S, Rademaker A et al. (1999) Analysis of sperm chromosome complements before, during, and after chemotherapy. Cancer Genet Cytogenet 108: 133–6PubMedCrossRefGoogle Scholar
  89. 89.
    Martin RH, Ernst S, Rademaker A et al. (1997) Analysis of human sperm karyotypes in testicular cancer patients before and after chemotherapy. Cytogenet Cell Genet 78: 120–3PubMedCrossRefGoogle Scholar
  90. 90.
    Martin RH, Ernst S, Rademaker A et al. (1997) Chromosomal abnormalities in sperm from testicular cancer patients before and after chemotherapy. Hum Genet 99: 214–8PubMedCrossRefGoogle Scholar
  91. 91.
    De Mas P, Daudin M, Vincent MC et al. (2001) Increased aneuploidy in spermatozoa from testicular tumour patients after chemotherapy with cisplatin, etoposide and bleomycin. Hum Reprod 16: 1204–8PubMedGoogle Scholar
  92. 92.
    Chevreau C, Huguet F (1995) Chimiothérapie anticancéreuse et fertilité masculine. Andrologie 5: 458–64Google Scholar
  93. 93.
    Drasga RE, Einhorn LH, Williams SD et al. (1983) Fertility after chemotherapy for testicular cancer. J Clin Oncol 1: 179–83PubMedGoogle Scholar
  94. 94.
    Jewett MA, Thachil JV, Harris JF (1983) Exocrine function of testis with germinal testicular tumour. Br Med J (Clin Res Ed) 286: 1849–50CrossRefGoogle Scholar
  95. 95.
    Horwich A, Nicholls EJ, Hendry WF (1988) Seminal analysis after orchiectomy in stage I teratoma. Br J Urol 62: 79–81PubMedCrossRefGoogle Scholar
  96. 96.
    Dearnaley DP, Horwich A, A’Hern R et al. (1991) Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term followup. Eur J Cancer 27: 684–91PubMedGoogle Scholar
  97. 97.
    Reiter WJ, Kratzik C, Brodowicz T et al. (1998) Sperm analysis and serum follicle-stimulating hormone levels before and after adjuvant single-agent carboplatin therapy for clinical stage I seminoma. Urology 52: 117–9PubMedCrossRefGoogle Scholar
  98. 98.
    Tomomasa H, Oshio S, Ashizawa Y et al. (2002) Gonadal function in patients with testicular germ cell tumors. Arch Androl 48: 405–15PubMedCrossRefGoogle Scholar
  99. 99.
    Pectasides D, Pectasides M, Farmakis D et al. (2004) Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC(90)) combination chemotherapy. Eur Urol 45: 187–93PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag France, Paris 2006

Authors and Affiliations

  • É. Huyghe
    • 1
  • P.-F. Thonneau
    • 1
  1. 1.Service d’urologie du Pr PlanteToulouse Cedex 9

Personalised recommendations